BioNTech unveils AI advancements in immunotherapy

LONDON - BioNTech SE (NASDAQ:BNTX), in collaboration with its AI subsidiary InstaDeep Ltd., has presented an update on its artificial...
12 hours ago
from: Investing.com

Artificial intelligence, Research and development

More about this

- BioNTech highlights AI capabilities, R&D use cases at AI Day
BioNTech presents an overview of its AI approach during an edition of the Company's Innovation Series, AI Day. “At BioNTech, we are at the...
from: TipRanks

- BioNTech Unveils AI Advancements in Immunotherapy
BioNTech SE, in partnership with its AI subsidiary InstaDeep, is revolutionizing immunotherapy by scaling and integrating advanced AI...
from: TipRanks